ArticleFrontiers in immunology2022
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease.
Elizabeth Stenger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it